NervGen Pharma Corp.
NGENF
$2.15
-$0.0182-0.84%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 35.93% | 42.28% | 59.78% | 68.02% | -46.78% |
| Total Receivables | 87.97% | -72.09% | -72.28% | -85.01% | 847.50% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 58.66% | 15.61% | 59.21% | 46.31% | 37.41% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 92.83% | 18.06% | 4.15% | 192.77% | -13.35% |
| Total Current Assets | 39.43% | 40.85% | 57.82% | 68.81% | -44.59% |
|
|
|||||
| Total Current Assets | 39.43% | 40.85% | 57.82% | 68.81% | -44.59% |
| Net Property, Plant & Equipment | -- | -99.16% | -98.98% | -34.73% | -30.66% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -18.06% | -10.32% | 16.16% | 20.32% | 23.68% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 35.13% | 37.46% | 54.94% | 66.28% | -43.19% |
|
|
|||||
| Total Accounts Payable | -- | -27.58% | -38.96% | 154.14% | 70.02% |
| Total Accrued Expenses | -- | 25.09% | 60.83% | 49.71% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -2.59% | 6.30% | 2.83% | 6.18% | 8.95% |
| Total Finance Division Other Current Liabilities | -7.15% | 21.37% | 63.36% | 35.65% | 78.51% |
| Total Other Current Liabilities | -7.15% | 21.37% | 63.36% | 35.65% | 78.51% |
| Total Current Liabilities | 2.46% | 19.25% | 52.96% | 42.25% | 51.86% |
|
|
|||||
| Total Current Liabilities | 2.46% | 19.25% | 52.96% | 42.25% | 51.86% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -92.75% | -74.21% | -63.24% | -53.25% | -45.09% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.81% | 18.18% | 51.17% | 40.43% | 50.02% |
|
|
|||||
| Common Stock & APIC | 26.31% | 37.18% | 32.17% | 37.25% | 5.20% |
| Retained Earnings | -19.98% | -34.70% | -30.98% | -32.99% | -43.61% |
| Treasury Stock & Other | 26.04% | 40.06% | 41.44% | 59.02% | 49.23% |
| Total Common Equity | 217.72% | 79.95% | 59.85% | 90.41% | -115.30% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 217.72% | 79.95% | 59.85% | 90.41% | -115.30% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 217.72% | 79.95% | 59.85% | 90.41% | -115.30% |
|
|
|||||